cDC2 Cancer Research Results
cDC2, type 2 conventional dendritic cell: Click to Expand ⟱
| Source: |
| Type: |
Play an important role in antitumor immunity by promoting cytotoxic T-cell responses and helper T-cell differentiation.
Dendritic cells (DCs) consist of three major subsets termed plasmacytoid (pDCs), type-1 (cDC1s), and type-2 (cDC2s) conventional (or classical) DCs.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
AML, |
HL-60 |
|
|
|
- |
in-vitro, |
AML, |
K562 |
|
|
|
- |
in-vitro, |
AML, |
TF1 |
|
|
|
JAK↓, PI3K↓, cDC2↓, STAT↓,
| - |
in-vitro, |
Colon, |
HCT116 |
|
|
|
CycB/CCNB1↓, cDC2↓, CDC25↓, P53↑, P21↑, cl‑PARP↑, proCasp8↓, proCasp9↓, proCasp3↓,
| - |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
ROS↑, Bcl-2↓, PARP↑, cDC2↓, CycB/CCNB1↓, MDM2↓, eff↓, eIF2α↑, ATF4↑, CHOP↑, ER Stress↑, TumCCA↑,
| - |
in-vitro, |
BC, |
T47D |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-468 |
|
|
|
CDC25↓, cDC2↓, P21↑, p‑Akt↓, p‑mTOR↓, Bcl-2↓, BAX↑, Casp3↑,
TumCCA↑, P21↑, Chk2↑, CycB/CCNB1↓, cDC2↓, Apoptosis↑, Cyt‑c↑, Casp9↑, Casp3↑, ROS↑, MMP↓, Bax:Bcl2↑, ER Stress↑,
TumCG↓, ROS↑, P21↑, CycB/CCNB1↓, cDC2↓, CDC25↓, eff↓, TumCCA↑, Apoptosis↑,
P21↑, cDC2↓, CDK1↓, CycB/CCNB1↓, Casp3↑, Bcl-2↓, Bcl-xL↓, BAX↑, pRB↓, TumCCA↑, Apoptosis↑,
| - |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Pca, |
LNCaP |
|
|
|
cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4/6↓, E2Fs↓, PCNA↓, cDC2↓, PTEN↑, MSH2↑, P21↑, EP300↑, BRCA1↑, NF2↑, TSC1↑, TGFβR1↑, P53↑, RB1↑, AKT1↓, cMyc↓, CDC7↓, cycF↓, CDC16↓, CUL4B↑, CBP↑, TSC2↑, HER2/EBBR2↓, BCR↓, TumCCA↑, chemoPv↑,
tumCV↓, TumCCA↑, ROS↓, CycB/CCNB1↑, CycD3↑, cycA1/CCNA1↓, cycE/CCNE↓, cDC2↓, antiOx↑, PARP↓, NRF2↓, ARE/EpRE↑, eff↑,
Showing Research Papers: 1 to 9 of 9
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, ARE/EpRE↑, 1, NRF2↓, 1, ROS↓, 1, ROS↑, 3,
Mitochondria & Bioenergetics ⓘ
BCR↓, 1, CDC16↓, 1, CDC25↓, 3, MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
AKT1↓, 1, cMyc↓, 1,
Cell Death ⓘ
p‑Akt↓, 1, Apoptosis↑, 3, BAX↑, 2, Bax:Bcl2↑, 1, Bcl-2↓, 3, Bcl-xL↓, 1, Casp3↑, 3, proCasp3↓, 1, proCasp8↓, 1, Casp9↑, 1, proCasp9↓, 1, CBP↑, 1, Chk2↑, 1, Cyt‑c↑, 1, MDM2↓, 1,
Kinase & Signal Transduction ⓘ
CDC7↓, 1, HER2/EBBR2↓, 1, TSC2↑, 1,
Transcription & Epigenetics ⓘ
pRB↓, 1, tumCV↓, 1,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, eIF2α↑, 1, ER Stress↑, 2,
DNA Damage & Repair ⓘ
BRCA1↑, 1, CUL4B↑, 1, P53↑, 2, PARP↓, 1, PARP↑, 1, cl‑PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK1↓, 1, CDK2↓, 1, cycA1/CCNA1↓, 1, CycB/CCNB1↓, 5, CycB/CCNB1↑, 1, cycD1/CCND1↓, 1, CycD3↑, 1, cycE/CCNE↓, 2, cycF↓, 1, E2Fs↓, 1, P21↑, 6, RB1↑, 1, TumCCA↑, 6,
Proliferation, Differentiation & Cell State ⓘ
cDC2↓, 9, EP300↑, 1, p‑mTOR↓, 1, NF2↑, 1, PI3K↓, 1, PTEN↑, 1, STAT↓, 1, TumCG↓, 1,
Migration ⓘ
CDK4/6↓, 1, MSH2↑, 1, TSC1↑, 1,
Angiogenesis & Vasculature ⓘ
ATF4↑, 1,
Immune & Inflammatory Signaling ⓘ
JAK↓, 1,
Drug Metabolism & Resistance ⓘ
eff↓, 2, eff↑, 1,
Clinical Biomarkers ⓘ
BRCA1↑, 1, HER2/EBBR2↓, 1,
Functional Outcomes ⓘ
chemoPv↑, 1, TGFβR1↑, 1,
Total Targets: 73
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: cDC2, type 2 conventional dendritic cell
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:439 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page